Sale!

DARS2 Gene Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation Genetic Test

Original price was: $700.Current price is: $500.

-29%

The DARS2 Gene Leukoencephalopathy NGS Genetic DNA Test is a comprehensive diagnostic tool that identifies mutations in the DARS2 gene responsible for leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL). This rare neurological disorder affects the brain’s white matter and can cause progressive motor and cognitive symptoms. Using next-generation sequencing technology, our test provides precise detection of genetic variants, enabling accurate diagnosis and personalized treatment approaches. The test costs $500 USD and is particularly valuable for individuals experiencing unexplained neurological symptoms, those with family history of similar conditions, or patients with abnormal MRI findings showing characteristic white matter changes. Early genetic diagnosis can guide appropriate management strategies and provide crucial information for family planning decisions.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

DARS2 Gene Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation NGS Genetic DNA Test

Comprehensive Genetic Testing for Neurological Disorders

The DARS2 Gene Leukoencephalopathy NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise identification of mutations associated with leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL). This rare autosomal recessive disorder affects the central nervous system’s white matter and requires specialized genetic analysis for accurate diagnosis.

What This Advanced Test Detects

Our comprehensive NGS-based test specifically targets the DARS2 gene, which encodes mitochondrial aspartyl-tRNA synthetase. Mutations in this gene disrupt mitochondrial protein synthesis, leading to characteristic neurological manifestations. The test identifies:

  • Pathogenic variants in the DARS2 gene
  • Single nucleotide polymorphisms (SNPs) affecting protein function
  • Insertions and deletions that disrupt gene expression
  • Compound heterozygous mutations
  • Novel variants with potential clinical significance

Who Should Consider This Genetic Test?

This specialized genetic test is recommended for individuals presenting with specific neurological symptoms or clinical findings:

Clinical Indications and Symptoms

  • Progressive motor deterioration with spasticity and ataxia
  • Brainstem involvement symptoms including dysarthria and swallowing difficulties
  • Spinal cord abnormalities detected through imaging studies
  • Elevated lactate levels in blood or cerebrospinal fluid
  • Characteristic MRI findings showing white matter abnormalities
  • Family history of similar neurological conditions
  • Unexplained developmental regression in children
  • Suspected mitochondrial disorders with neurological presentation

Significant Benefits of Genetic Testing

Undergoing the DARS2 Gene Leukoencephalopathy NGS Test provides numerous advantages for patients and healthcare providers:

Diagnostic and Clinical Benefits

  • Accurate Diagnosis: Provides definitive genetic confirmation of LBSL
  • Personalized Treatment: Enables targeted therapeutic approaches
  • Prognostic Information: Helps predict disease progression and outcomes
  • Family Planning: Offers crucial information for genetic counseling
  • Early Intervention: Facilitates timely management strategies
  • Differential Diagnosis: Distinguishes LBSL from other leukodystrophies

Understanding Your Test Results

Our comprehensive genetic analysis provides detailed insights into your DARS2 gene status:

Result Interpretation Guidelines

  • Positive Result: Identifies pathogenic mutations confirming LBSL diagnosis
  • Negative Result: No mutations detected, though clinical correlation remains essential
  • Variant of Uncertain Significance: Requires additional family studies and clinical evaluation
  • Carrier Status: Identifies individuals with single mutation copies

All results are accompanied by detailed interpretation from our board-certified genetic specialists, ensuring you receive comprehensive guidance for next steps.

Test Details and Pricing

Test Component Details
Test Name DARS2 Gene Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified collection centers ensures accessible testing for patients nationwide.

Take the Next Step Toward Diagnosis

Don’t let uncertainty about neurological symptoms delay your path to accurate diagnosis. Our specialized genetic testing provides the clarity needed for informed medical decisions and personalized treatment planning.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your DARS2 Gene Leukoencephalopathy NGS Genetic DNA Test and take control of your neurological health.

Our experienced genetic counselors are available to discuss your specific situation, answer questions about the testing process, and help you understand how genetic testing can benefit your healthcare journey.